RSS Feeds   Print News Release  

Jenex Issues Product Development Update

Toronto, Ontario--(Newsfile Corp. - September 30, 2016) - The Jenex Corporation (TSXV: JEN.H) ("Jenex" or the "Company").

Jenex would like to announce the Company has made tangible progress in its product development efforts related to its next generation insect device. Jenex has worked closely with engineering, industrial design and legal experts with a detailed plan to develop a device subject to financing or signing of a licensing contract. The new insect device will provide Jenex with intellectual property including trademark opportunities. The intellectual property for the Therapik device has expired and the Company no longer holds the patent or trademark for Therapik. Jenex will report further information on product development in the near future. As previously reported Jenex continues to pursue the retail channel for its InterceptCS device and continues to investigate a proposed financing or licensing contract to finance product development and marketing.

Forward Looking Statements

This press release contains forward-looking statements. More particularly, this press release contains statements which include the timing of closing the offering, the anticipated use of proceeds and the receipt of the required approvals. The forward-looking statements are based on certain expectations and assumptions made by Jenex. Although Jenex believes that those expectations and assumptions are reasonable, undue reliance should not be placed on the forward-looking statements because Jenex can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results could differ materially from those anticipated due to a number of factors and risks. In addition to other risks, the closing of the offering could be delayed if Jenex is not able to obtain necessary approvals when planned and the offering will not be completed at all if approvals are not obtained or some other condition to the closing is not satisfied. Accordingly, there is a risk that the offering will not be completed within the anticipated time or at all. The intended use of the net proceeds of the offering by Jenex might change if Jenex determines that it would be in the best interests of Jenex to use the proceeds for some other purpose. The forward-looking statements contained in this press release are made as of the date hereof. Jenex disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required under applicable securities laws.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

For Further information please contact:

The Jenex Corporation
Rob Fia
CEO & Chairman
Phone:           (416) 722-4994
e-mail: rfia@thejenexcorporation.com

NOT FOR DISSEMINATION OR DISTRIBUTION IN THE UNITED STATES
Copyright 2017 Newsfile Corp. All rights reserved.
Terms and Conditions of Use | Privacy Policy | Anti-Spam Policy | Contact Us